[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Viral Vectors and Plasmid DNA Manufacturing Market Report (Status and Outlook)

September 2018 | 131 pages | ID: 21246941268EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Viral Vectors and Plasmid DNA Manufacturing market for 2018-2023.

The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accounted for larger market share in terms of sales in 2016, vascular segmented accounted for more than 61% of the market share in 2016.
North America is the largest consumption place, with a consumption market share nearly 51% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 34% in 2016.
Market competition is intense among top 5. BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Over the next five years, LPI(LP Information) projects that Viral Vectors and Plasmid DNA Manufacturing will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Viral Vectors and Plasmid DNA Manufacturing market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Plasmid DNA
  • Viral Vectors
Segmentation by application:
  • Cancers
  • Inherited Disorders
  • Viral Infections
  • Others
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • BioReliance
  • Cobra Biologics
  • Oxford BioMedica
  • UniQure
  • FinVector
  • MolMed
  • MassBiologics
  • Richter-Helm
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Aldevron
  • Eurogentec
  • Cell and Gene Therapy Catapult
  • Biovian
  • Brammer Bio
  • VGXI
  • PlasmidFactory
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Viral Vectors and Plasmid DNA Manufacturing market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Viral Vectors and Plasmid DNA Manufacturing market by identifying its various subsegments.
  • Focuses on the key global Viral Vectors and Plasmid DNA Manufacturing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Viral Vectors and Plasmid DNA Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Viral Vectors and Plasmid DNA Manufacturing submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size 2013-2023
  2.1.2 Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Region
2.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Type
  2.2.1 Plasmid DNA
  2.2.2 Viral Vectors
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
  2.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2013-2018)
  2.3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (2013-2018)
2.4 Viral Vectors and Plasmid DNA Manufacturing Segment by Application
  2.4.1 Cancers
  2.4.2 Inherited Disorders
  2.4.3 Viral Infections
  2.4.4 Others
2.5 Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
  2.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2013-2018)
  2.5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application (2013-2018)

3 GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING BY PLAYERS

3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Players
  3.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Players (2016-2018)
  3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Players (2016-2018)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VIRAL VECTORS AND PLASMID DNA MANUFACTURING BY REGIONS

4.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions
4.2 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Growth
4.3 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Growth
4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth
4.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth

5 AMERICAS

5.1 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Countries
5.2 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
5.3 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Countries
6.2 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
6.3 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Viral Vectors and Plasmid DNA Manufacturing by Countries
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing by Countries
8.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
8.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET FORECAST

10.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast (2018-2023)
10.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Regions
  10.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Type
10.8 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 BioReliance
  11.1.1 Company Details
  11.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 BioReliance News
11.2 Cobra Biologics
  11.2.1 Company Details
  11.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Cobra Biologics News
11.3 Oxford BioMedica
  11.3.1 Company Details
  11.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Oxford BioMedica News
11.4 UniQure
  11.4.1 Company Details
  11.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 UniQure News
11.5 FinVector
  11.5.1 Company Details
  11.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 FinVector News
11.6 MolMed
  11.6.1 Company Details
  11.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 MolMed News
11.7 MassBiologics
  11.7.1 Company Details
  11.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 MassBiologics News
11.8 Richter-Helm
  11.8.1 Company Details
  11.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Richter-Helm News
11.9 FUJIFILM Diosynth Biotechnologies
  11.9.1 Company Details
  11.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 FUJIFILM Diosynth Biotechnologies News
11.10 Lonza
  11.10.1 Company Details
  11.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
  11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Lonza News
11.11 Aldevron
11.12 Eurogentec
11.13 Cell and Gene Therapy Catapult
11.14 Biovian
11.15 Brammer Bio
11.16 VGXI
11.17 PlasmidFactory

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Viral Vectors and Plasmid DNA Manufacturing
Figure Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure Market Research Methodology
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate 2013-2023 ($ Millions)
Table Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Plasmid DNA
Table Major Players of Viral Vectors
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2013-2018)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2013-2018)
Figure Global Plasmid DNA Market Size Growth Rate
Figure Global Viral Vectors Market Size Growth Rate
Figure Viral Vectors and Plasmid DNA Manufacturing Consumed in Cancers
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market: Cancers (2013-2018) ($ Millions)
Figure Global Cancers YoY Growth ($ Millions)
Figure Viral Vectors and Plasmid DNA Manufacturing Consumed in Inherited Disorders
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market: Inherited Disorders (2013-2018) ($ Millions)
Figure Global Inherited Disorders YoY Growth ($ Millions)
Figure Viral Vectors and Plasmid DNA Manufacturing Consumed in Viral Infections
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market: Viral Infections (2013-2018) ($ Millions)
Figure Global Viral Infections YoY Growth ($ Millions)
Figure Viral Vectors and Plasmid DNA Manufacturing Consumed in Others
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2013-2018) ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2013-2018)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2013-2018)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size in Cancers Growth Rate
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size in Inherited Disorders Growth Rate
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size in Viral Infections Growth Rate
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size in Others Growth Rate
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2016-2018) ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2016-2018)
Figure Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players in 2017
Table Global Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Products Offered
Table Viral Vectors and Plasmid DNA Manufacturing Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions 2013-2018 ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Regions 2013-2018
Figure Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Regions 2013-2018
Figure Americas Viral Vectors and Plasmid DNA Manufacturing Market Size 2013-2018 ($ Millions)
Figure APAC Viral Vectors and Plasmid DNA Manufacturing Market Size 2013-2018 ($ Millions)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2013-2018 ($ Millions)
Table Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Countries (2013-2018) ($ Millions)
Table Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Countries (2013-2018)
Figure Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Countries in 2017
Table Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2013-2018) ($ Millions)
Table Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2013-2018)
Figure Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2017
Table Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2013-2018) ($ Millions)
Table Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2013-2018)
Figure Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2017
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Canada Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Table APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Countries (2013-2018) ($ Millions)
Table APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Countries (2013-2018)
Figure APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Countries in 2017
Table APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2013-2018) ($ Millions)
Table APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2013-2018)
Figure APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2017
Table APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2013-2018) ($ Millions)
Table APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2013-2018)
Figure APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2017
Figure China Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Japan Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Korea Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure India Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Australia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Countries (2013-2018) ($ Millions)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Countries (2013-2018)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Countries in 2017
Table Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2013-2018) ($ Millions)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2013-2018)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2017
Table Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2013-2018) ($ Millions)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2013-2018)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2017
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure France Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Spain Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Countries in 2017
Table Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type in 2017
Table Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application in 2017
Figure Egypt Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Israel Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Viral Vectors and Plasmid DNA Manufacturing Market Size Growth 2013-2018 ($ Millions)
Figure Global Viral Vectors and Plasmid DNA Manufacturing arket Size Forecast (2018-2023) ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Regions
Figure Americas Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure APAC Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure United States Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Canada Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure China Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Japan Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Korea Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure India Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Australia Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure France Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Spain Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Egypt Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure South Africa Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Israel Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Figure GCC Countries Viral Vectors and Plasmid DNA Manufacturing Market Size 2018-2023 ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Type (2018-2023)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share Forecast by Application (2018-2023)
Table BioReliance Basic Information, Head Office, Major Market Areas and Its Competitors
Table BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure BioReliance Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table Cobra Biologics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table Oxford BioMedica Basic Information, Head Office, Major Market Areas and Its Competitors
Table Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table UniQure Basic Information, Head Office, Major Market Areas and Its Competitors
Table UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure UniQure Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table FinVector Basic Information, Head Office, Major Market Areas and Its Competitors
Table FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure FinVector Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table MolMed Basic Information, Head Office, Major Market Areas and Its Competitors
Table MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure MolMed Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table MassBiologics Basic Information, Head Office, Major Market Areas and Its Competitors
Table MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure MassBiologics Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table Richter-Helm Basic Information, Head Office, Major Market Areas and Its Competitors
Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table FUJIFILM Diosynth Biotechnologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table Lonza Basic Information, Head Office, Major Market Areas and Its Competitors
Table Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue and Gross Margin (2016-2018)
Figure Lonza Viral Vectors and Plasmid DNA Manufacturing Market Share (2016-2018)
Table Aldevron Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eurogentec Basic Information, Head Office, Major Market Areas and Its Competitors
Table Cell and Gene Therapy Catapult Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biovian Basic Information, Head Office, Major Market Areas and Its Competitors
Table Brammer Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table VGXI Basic Information, Head Office, Major Market Areas and Its Competitors
Table PlasmidFactory Basic Information, Head Office, Major Market Areas and Its Competitors


More Publications